Related references
Note: Only part of the references are listed.Repurposing strategies for Chagas disease therapy: the effect of imatinib and derivatives against Trypanosoma cruzi
M. R. Simoes-Silva et al.
PARASITOLOGY (2019)
Mitochondrial disfunction and ROS production are essential for anti-Trypanosoma cruzi activity of β-lapachone-derived naphthoimidazoles
Ana Cristina S. Bombaca et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
Daiane Dias Ferreira et al.
JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES (2018)
Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08-20
Yehuda Patt et al.
ONCOLOGIST (2017)
Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
Hanna-Riikka Teppo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Defining the target and the effect of imatinib on the filarial c-Abl homologue
Elise M. O'Connell et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases
Maria Dichiara et al.
CHEMMEDCHEM (2017)
Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells
Matthias Lange et al.
BIOCHEMICAL PHARMACOLOGY (2016)
A Clinical and Epidemiological Investigation of the First Reported Human Infection With the Zoonotic Parasite Trypanosoma evansi in Southeast Asia
Nguyen Van Vinh Chau et al.
CLINICAL INFECTIOUS DISEASES (2016)
Recent Development in Identification of Potential Novel Therapeutic Targets Against Trypanosomatids
Rajender Kumar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Cytotoxicity and genotoxicity of a trypanocidal drug quinapyramine sulfate loaded-sodium alginate nanoparticles in mammalian cells
Anju Manuja et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Glycogen Synthase Kinase 3β Promotes the Endocytosis of Transferrin in the African Trypanosome
Paul J. Guyett et al.
ACS INFECTIOUS DISEASES (2016)
Clinical development of imatinib: an anticancer drug
Dipanjan Goswami et al.
FUTURE SCIENCE OA (2016)
Tyrosine kinase inhibitors: New class of antimalarials on the horizon?
Vrushali Pathak et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration-Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and Macrofilaricidal
Elise M. O'Connell et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Genome and Phylogenetic Analyses of Trypanosoma evansi Reveal Extensive Similarity to T. brucei and Multiple Independent Origins for Dyskinetoplasty
Jason Carnes et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
New Chemical Scaffolds for Human African Trypanosomiasis Lead Discovery from a Screen of Tyrosine Kinase Inhibitor Drugs
Ranjan Behera et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites
Christopher Merritt et al.
CHEMICAL REVIEWS (2014)
Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
Lisa Sanderson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Imatinib Treatment Causes Substantial Transcriptional Changes in Adult Schistosoma mansoni In Vitro Exhibiting Pleiotropic Effects
Christin Buro et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib
Svenja Beckmann et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)
Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling
J. Wan et al.
BRITISH JOURNAL OF CANCER (2013)
Mitochondria and Reactive Oxygen Species: Physiology and Pathophysiology
Subhashini Bolisetty et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Reactive Oxygen Species Production by Quercetin Causes the Death of Leishmania amazonensis Intracellular Amastigotes
Fernanda Fonseca-Silva et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Development of an antibody-ELISA for seroprevalence of Trypanosoma evansi in equids of North and North-western regions of India
Rajender Kumar et al.
VETERINARY PARASITOLOGY (2013)
Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development
G. Ranieri et al.
CURRENT MEDICINAL CHEMISTRY (2012)
The Abl and Arg Kinases Mediate Distinct Modes of Phagocytosis and Are Required for Maximal Leishmania Infection
Dawn M. Wetzel et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
Romain Coriat et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Imatinib mesylate induction of ROS-dependent apoptosis in melanoma B16F0 cells
Shao-Ping Chang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Reactive Oxygen Species Production and Mitochondrial Dysfunction Contribute to Quercetin Induced Death in Leishmania amazonensis
Fernanda Fonseca-Silva et al.
PLOS ONE (2011)
2′,7′-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy
Xiuping Chen et al.
FREE RADICAL RESEARCH (2010)
Development of a mathematical model for mechanical transmission of trypanosomes and other pathogens of cattle transmitted by tabanids
Marc Desquesnes et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2009)
Protein kinase inhibitors: contributions from structure to clinical compounds
Louise N. Johnson
QUARTERLY REVIEWS OF BIOPHYSICS (2009)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Short report:: Human trypanosomiasis caused by Trypanosoma evansi in a village in india:: Preliminary serologic survey of the local population
Vijay R. Shegokar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2006)
Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders
A Pardanani et al.
BLOOD (2004)
Share Paper
